Cargando…
Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility
While progress has been made in treating cancer, cytotoxic chemotherapeutic agents are still the most widely used drugs and are associated with severe side-effects. Drugs that target unique molecular signalling pathways are needed for treating cancer with low or no intrinsic toxicity to normal cells...
Autores principales: | Ferguson, Jalisa H., De Los Santos, Zeus, Devi, Saroja N., Kaluz, Stefan, Van Meir, Erwin G., Zingales, Sarah K., Wang, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009948/ https://www.ncbi.nlm.nih.gov/pubmed/28766956 http://dx.doi.org/10.1080/14756366.2017.1347784 |
Ejemplares similares
-
Taking a HIF pill for old age diseases?
por: Kaluz, Stefan, et al.
Publicado: (2018) -
A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis
por: Dai, Xin, et al.
Publicado: (2017) -
Magnet-responsive choline carbomer ionogels as a versatile and recyclable catalyst for one-pot synthesis of benzopyran in water
por: Shojaee, Sara, et al.
Publicado: (2023) -
Synthesis of Polycyclic Ether-Benzopyrans and In Vitro Inhibitory Activity against Leishmania tarentolae
por: Singh, Sarita, et al.
Publicado: (2020) -
Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds
por: Gupta, Shilpi, et al.
Publicado: (2023)